# Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe

> **NCT02943993** · — · COMPLETED · sponsor: **Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company** · enrollment: 2809 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Edoxaban

## Key facts

- **NCT ID:** NCT02943993
- **Lead sponsor:** Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-06
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 2809 (ACTUAL)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02943993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02943993, "Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02943993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*